Results 91 to 100 of about 6,359 (195)

Clinical performance of the OMV inhaler [PDF]

Anaesthesia, 1966
openaire   +2 more sources

Green Hydrogen @ OMV (Technology Talk)

Die NEFI Technology Talk-Veranstaltung „Hydrogen Valley meets NEFI – Best Practices für Österreichs H₂-Zukunft“ von der Business Upper Austria im Rahmen von NEFI fand am 23.10.2025 in der Tabakfabrik in Linz statt und fokussierte sich auf die Rolle von Wasserstoff als Schlüssel für eine klimaneutrale Industrie. Expert*innen aus Politik, Wirtschaft und
openaire   +2 more sources

A Randomized, Double-Blind, Placebo-Controlled Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an Outer Membrane Vesicle (OMV) Platform-Based Vaccine Administered Intranasally to Healthy Adults

Vaccines
Background: The COVID-19 pandemic exposed critical gaps in pandemic preparedness and highlighted the need for vaccine platforms capable of rapid adaptation.
Heleen Kraan, Anne van der Geest, Dinja Oosterhoff, Corine Kruiswijk, Peter Soema   +4 more
doaj   +1 more source

Oxidative Stress Reshapes Porphyromonas gingivalis Outer Membrane Vesicles and Impairs OMV-Mediated Invasion and Persistence in Trophoblast Cells

Antibiotics
Background: Porphyromonas gingivalis outer membrane vesicles (OMVs) are key mediators of host–pathogen interactions and have been implicated in both periodontal disease and systemic conditions, including pregnancy complications.
Ailén Fretes, Brenda Lara, Mateo N. Diaz Appella, Carolina López, Claudia Pérez Leirós, Paula M. Tribelli, Vanesa Hauk   +6 more
doaj   +1 more source

Investigation on antigen-specific T-cell responses induced by outer membrane vesicles from Escherichia coli Δ60 strain

Frontiers in Immunology
There is a growing interest in the exploitation of bacterial outer membrane vesicles (OMVs) for the design of vaccines and novel antitumor immunotherapeutic products.
Michele Tomasi, Lorenzo Croia, Ilaria Zanella, Assunta Gagliardi, Giulia Boscato Sopetto, Mattia Benedet, Gabriele Di Lascio, Gaia Gambini, Alvise Berti, Riccardo Corbellari, Guido Grandi, Guido Grandi, Alberto Grandi, Alberto Grandi   +13 more
doaj   +1 more source

Modular engineered outer membrane vesicles for synergistic cancer immunotherapy via PD-L1 blockade and epigenetic reprogramming

Frontiers in Immunology
Immune checkpoint inhibitors have significantly improved therapeutic outcomes in advanced melanoma; however, their clinical efficacy is greatly limited by low overall response rates and the primary or acquired resistance.
Longxue Guan, Longxue Guan, Qinxiao Sun, Dandan Liang, Zhimin Li, Shiqi Zhang, Laili Huang, Xingang Guan, Hongxia Feng   +8 more
doaj   +1 more source

Immunogenicity of meningococcal PorA antigens in OMV vaccines.

, 2006
For the prevention of meningococcal infection caused by group B meningococci, the Netherlands Vaccine Institute (NVI) has developed a hexavalent Porin A (PorA) based Outer Membrane Vesicle (OMV) vaccine (Hexamen). In various clinical studies with HexaMen, differences in the immune responses to the individual PorAs were observed. Factors involved in the
openaire   +2 more sources

Outer membrane vesicles in <i>Vibrio</i> species: Roles in biofilm formation and pathogenesis. [PDF]

Microb Cell
Shambhavi K, Singh DV.
europepmc   +1 more source

Investigation of Correlates of Protection Against Gonococcal Infection by Comparative Immunoprofiling of Responses in Experimental and Clinical Studies. [PDF]

J Infect Dis
McKeand SA, Bencomo FR, Soc A, Jones RA, Thistlethwaite A, Gu Z, Nduati E, Sanders EJ, Jerse AE, Derrick JP, Tang CM.   +10 more
europepmc   +1 more source

Deciphering macrophage molecular responses to <i>Porphyromonas gingivalis</i> outer membrane vesicles through combined immunoassay and Raman spectroscopic analyses. [PDF]

Front Microbiol
Matsuo Y, Son A, Gentile S, Bernola R, Yamashita T, Ikegami S, Sileo L, Ardondi L, Kariu T, Zavan B, Zhu W, Franceschini D, Bevilacqua E, Koutsikos K, Rigon L, Kamioka Y, Secci D, Pinton P, Pezzotti G.   +18 more
europepmc   +1 more source